Donor lymphocyte infusion post-non-myeloablative allogeneic peripheral blood stem cell transplantation for chronic granulomatous disease

Bone Marrow Transplantation

Volumn 24, Issue 3, 1999, Pages 339-342

  Nagler, A ^a   Ackerstein, A ^a   Kapelushnik, J ^a   Or, R ^a   Naparstek, E ^a   Slavin, S ^a  

^a HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

Author keywords

Anti T lymphocyte globulin; Chronic granulomatous disease; Donor lymphocyte infusion; Fludarabine; Non myeloablative

Indexed keywords

BUSULFAN; FLUDARABINE; GAMMA INTERFERON; ITRACONAZOLE; STEROID; SULFAMETHIZOLE; SUPEROXIDE; THYMOCYTE ANTIBODY; TRIMETHOPRIM;

ALLOGENIC BONE MARROW TRANSPLANTATION; ARTICLE; CASE REPORT; CHIMERA; CHRONIC GRANULOMATOUS DISEASE; CLUBBING FINGERS; GRAFT VERSUS HOST REACTION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HLA MATCHING; HUMAN; LUNG FUNCTION; LUNG INFECTION; LYMPHOCYTE TRANSFUSION; MALE; MUCOSA INFLAMMATION; PRESCHOOL CHILD; PRIORITY JOURNAL; STEROID THERAPY; THROMBOCYTE COUNT; TREATMENT FAILURE;

EID: 0032784069     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bmt.1701903     Document Type: Article

References (36)

1. Fischer A, Segal AW, Seger R, Weening RS. The management of chronic granulomatous disease. Eur J Pediatr 1993; 152: 896-899.
2. Verhoeven AJ. The NADPH oxidase: lessons from chronic granulomatous disease neutrophils. Ann NY Acad Sci 1997; 832: 85-92.
3. Roos D, de Boer M, Kunbayashi F et al. Mutations in the X-linked and autosomal recessive forms of chronic granulomatous disease. Blood 1996; 87: 1663-1681.
4. Thrasher AJ, Keep NH, Wientjes F, Segal AW. Chronic granulomatous disease. Biochim Biophys Acta 1994; 1227: 1-24.
5. Roos D. The genetic basis of chronic granulomatous disease. Immunol Rev 1994; 138: 121-157.
6. Forehand JR, Johnston RB Jr. Chronic granulomatous disease: newly defined molecular abnormalities explain disease variability and normal phagocyte physiology. Curr Opin Pediatr 1994; 6: 668-675.
7. Naumovski L, Smith SD. Current therapy for chronic granulomatous disease. J Pediatr 1989; 114: 1066 (letter).
8. Forrest CB, Forehand JR, Axtell RA et al. Clinical features and current management of chronic granulomatous disease. Hematol Oncol Clin North Am 1988; 2: 253-266.
9. Oszahim H, von Planta M, Müller I et al. Successful treatment of invasive aspergillosis in chronic granulomatous disease by bone marrow transplantation, granulocyte colony-stimulating factor-mobilized granulocytes, and liposomal amphotericin-B. Blood 1998; 92: 2719-2724.
10. Goudemand J, Anssens R, Delmas-Marsalet Y et al. Essai de traitement d'un cas de granulomatose familiale chronique par greffe de moelle osseuse allogenique. Arch Franc Ped 1976; 33: 121-129.
11. Foroozanfar N, Hobbs JR, Hugh-Jones K et al. Bone marrow transplantation from an unrelated donor for chronic granulomatous disease. Lancet 1977; 1: 210-213.
12. Hobbs JR. Bone marrow transplantation for inborn errors. Lancet 1981; 2: 735-739.
13. Rappeport JM, Newburger PE, Goldblum RM et al. Allogeneic bone marrow transplantation for chronic granulomatous disease. J Pediatr 1982; 101: 952-955.
14. Kamani N, August CS, Douglas SD et al. Bone marrow transplantation in chronic granulomatous disease. Pediatr 1984; 105: 42-4.
15. di Bartolomeo P, di Girolamo G, Angrilli F et al. Reconstitution of normal neutrophil function in chronic granulomatous disease by bone marrow transplantation. Bone Marrow Transplant 1989; 4: 695-700.
16. Hobbs JR, Monteil M, McClusey DR et al. Chronic granulomatous disease 100% corrected by displacement bone marrow transplantation from a volunteer unrelated donor. Eur J Pediatr 1992; 151: 806-810.
17. Calvino MC, Maldonado MS, Otheo E et al. Bone marrow transplantation in chronic granulomatous disease. Eur J Pediatr 1996; 156: 877-879.
18. Ho CM, Vowels MR, Lockwood L, Ziegler JB. Successful bone marrow transplantation in a child with X-linked chronic granulomatous disease. Bone Marrow Transplant 1996; 18: 213-215.
19. Nakamura Y, Leppert M, O'Connell P et al. Variable number of tandem repeats (VNTR) markers for human gene mapping. Science 1987; 235: 1616-1622.
20. Beutler E. Bone marrow transplantation beyond treatment of aplasia and neoplasia. West J Med 1994; 160: 129-132.
21. Slavin S, Nagler A, Naparstek E et al. Nonmyeloablative stem cell transplantation and cell therapy as an alternative to conventional bone marrow transplantation with lethal cytoreduction for the treatment of malignant and nonmalignant hematologic diseases. Blood 1998; 91: 756-763.
22. Aker M, Kapelushnik J, Pugatsch T et al. Donor lymphocyte infusions to displace residual host hematopoietic cells after allogeneic BMT for beta thalassemia major. J Ped Hematol/Oncol 1998; 20: 145-149.
23. Kapelushnik J, Or R, Aker M et al. Allogeneic cell therapy of severe beta thalassemia major by displacement of host stem cells in mixed chimera by donor blood lymphocytes. Bone Marrow Transplant 1997; 19: 96-98.
24. Or R, Kapelushnik J, Naparstek E et al. Second transplantation using allogeneic peripheral blood stem cells in a β-thalassemia major patient featuring stable mixed chimaerism. Br J Haematol 1996; 94: 285-287.
25. Bohler MC, Seger RA, Mouy R et al. A study of 25 patients with chronic granulomatous disease: a new classification correlating respiratory burst, cytochrome B, and flavoprotein. J Clin Immunol 1986; 6: 136-145.
26. Pugatsch T, Oppenheim A, Slavin S. Improved single-step PCR assay for sex identification post-allogeneic sex-mismatched BMT. Bone Marrow Transplant 1996; 17: 273-275.
27. Devergie A, Gluckman E. Aspergillose invasive et allogreffe de moelle. Pathol Biol (Paris) 1994; 42: 652-655.
28. Bushhouse S, Ramsay NKC, Pescovitz OH et al. Growth in children following irradiation for bone marrow transplantation. Am J Ped Hematol/Oncol 1989; 11: 134-140.
29. Giralt S, Estey E, Albitar M et al. Engraftment of allogeneic hematopoietic progenitor cells with purine analog-containing chemotherapy: harnessing graft-versus-leukemia without myeloablative therapy. Blood 1997; 12: 4531-4536.
30. McSweeney PA, Wagner JL, Maloney DG et al. Outpatient PBSC allografts using immunosuppression after low-dose TBI before, and cyclosporine (CSP) and mycophenolate mofetil (MMF) after transplant. Blood 1998; 92 (Suppl. 1): 519a (Abstr. 2133).
31. Woolfrey AE, Nash RA, Frangoul HA et al. Non-myeloablative transplant regimen used for induction of multi-lineage allogeneic hematopoietic mixed donor-host chimerism in patients with T cell immunodeficiency. Blood 1998; 92 (Suppl. 1): 520a (Abstr. 2135).
32. Mardiney M III, Jackson SH, Spratt SK et al. Enhanced host defense after gene transfer in the murine p47phox-deficient model of chronic granulomatous disease. Blood 1997; 89: 2268-2275.
33. Lenarsky C, Parkman R. Bone marrow transplantation for the treatment of immune deficiency states. Bone Marrow Transplant 1990; 6: 361-369.
34. Mouy R, Veber F, Blanche S et al. Long term itraconazole prophylaxis against aspergillus infections in thirty-two patients with chronic granulomatous disease. J Pediatr 1994; 125: 998-1003.
35. A controlled trial of interferon gamma to prevent infection in chronic granulomatous disease. The International Chronic Granulomatous Disease Cooperative Study Group. New Engl J Med 1991; 324: 509-616.
36. Weening RG, Leitz GJ, Seger RA. Recombinant human interferon-gamma in patients with chronic granulomatous disease -European follow-up study. Eur J Pediatr 1995; 154: 295-298.